. Since its establishment in the first grant period, the Venom Resource Core has expanded to a collection of over 100 Conus species, and the facility has developed to a highly efficient operation for identification of specific venom components. Collection of Conus specimens from several countries will continue, but most of them will be obtained from various localities of the Philippines, the richest source of Conus species; about 200 of the 500 known species are found in the Philippines. In most cases, venom is processed in the Marine Science Institute of the University of the Philippines and transported to the University of Utah where a system for rapid assay, fractionation and purification has been developed; the collection of whole venom ducts and tissues (particularly hepatopancreas) has been greatly expanded. The latter are the starting point for molecular analyses. The Core will concentrate on two types of collection activities: (1) Increasing the amount of venom for new classes of fish-hunting species such as Conus bocki, C. bullatus, C. kinoshitai, C. parius, C. flavus, C. strioIatus, C. achatinus, C. spectrum and C. cinereus. (2) Obtaining tissues or preserved specimens of the remaining fish-hunting Conus species, including some that are either very rare of that come from inaccessible localities. Among these are Conus cervus, C. dusaveli, C. proximus, C. moIucensis, C. collisus and C. subulatus. Purified natural Conus peptides, synthetic peptides, derivatives and analogs will also be maintained by the core facility. The collection of venom ducts and other tissues from selected Conus species will be used for preparation of cDNA libraries which will be needed to rapidly expand conotoxin sequence databases through cDNA cloning. Furthermore, many thousands of venom ducts will be collected as part of our increasing efforts in the enzymology of post-translational modification.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Program Projects (P01)
Project #
5P01GM048677-12
Application #
7551072
Study Section
Special Emphasis Panel (ZRG1)
Project Start
Project End
Budget Start
2004-02-01
Budget End
2005-01-31
Support Year
12
Fiscal Year
2004
Total Cost
$126,107
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Yan, Yijin; Peng, Can; Arvin, Matthew C et al. (2018) Nicotinic Cholinergic Receptors in VTA Glutamate Neurons Modulate Excitatory Transmission. Cell Rep 23:2236-2244
Hone, Arik J; McIntosh, J Michael (2018) Nicotinic acetylcholine receptors in neuropathic and inflammatory pain. FEBS Lett 592:1045-1062
Hone, Arik J; Talley, Todd T; Bobango, Janet et al. (2018) Molecular determinants of ?-conotoxin potency for inhibition of human and rat ?6?4 nicotinic acetylcholine receptors. J Biol Chem 293:17838-17852
Banala, Sambashiva; Arvin, Matthew C; Bannon, Nicholas M et al. (2018) Photoactivatable drugs for nicotinic optopharmacology. Nat Methods 15:347-350
Hone, Arik J; Servent, Denis; McIntosh, J Michael (2018) ?9-containing nicotinic acetylcholine receptors and the modulation of pain. Br J Pharmacol 175:1915-1927
Espino, Samuel S; Robinson, Samuel D; Safavi-Hemami, Helena et al. (2018) Conopeptides promote itch through human itch receptor hMgprX1. Toxicon 154:28-34
Richter, Katrin; Sagawe, Sabrina; Hecker, Andreas et al. (2018) C-Reactive Protein Stimulates Nicotinic Acetylcholine Receptors to Control ATP-Mediated Monocytic Inflammasome Activation. Front Immunol 9:1604
Hiller, Sebastian Daniel; Heldmann, Sarah; Richter, Katrin et al. (2018) ?-Nicotinamide Adenine Dinucleotide (?-NAD) Inhibits ATP-Dependent IL-1? Release from Human Monocytic Cells. Int J Mol Sci 19:
Peng, Can; Yan, Yijin; Kim, Veronica J et al. (2018) Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission. Eur J Neurosci :
Chen, De-Jie; Gao, Fen-Fei; Ma, Xiao-Kuang et al. (2018) Pharmacological and functional comparisons of ?6/?3?2?3-nAChRs and ?4?2-nAChRs heterologously expressed in the human epithelial SH-EP1 cell line. Acta Pharmacol Sin 39:1571-1581

Showing the most recent 10 out of 277 publications